Rheonix CARD(®) Technology: An Innovative and Fully Automated Molecular Diagnostic Device.
暂无分享,去创建一个
Lincoln Young | Zongyuan Chen | Rubina Yasmin | Greg Mouchka | Richard Montagna | G. Spizz | Lincoln Young | Peng Zhou | R. Montagna | Zongyuan Chen | D. Mahoney | Gwendolyn Spizz | Travis Lee | Deborah Mahoney | Xun Zhang | Benjamin Thomas | Whitney Honey | Todd Roswech | Cristina McGuire | Peng Zhou | R. Yasmin | Travis M. Lee | Xun Zhang | Greg Mouchka | Benjamin Thomas | W. Honey | Todd Roswech | Cristina McGuire
[1] U. Schwarz,et al. Clinical relevance of genetic polymorphisms in the human CYP2C9 gene , 2003, European journal of clinical investigation.
[2] Lincoln Young,et al. Weak solvent based chip lamination and characterization of on-chip valve and pump , 2010, Biomedical microdevices.
[3] M. Urdea,et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology , 1996, Journal of clinical microbiology.
[4] S. Cichon,et al. Pharmacogenetics of schizophrenia. , 2000, American journal of medical genetics.
[5] E. Wagar. Direct hybridization and amplification applications for the diagnosis of infectious diseases , 1996, Journal of clinical laboratory analysis.
[6] D. Persing,et al. Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR , 1995, Journal of clinical microbiology.
[7] M. Houghton,et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.
[8] J. Oldenburg,et al. VKORC1: molecular target of coumarins , 2007, Journal of thrombosis and haemostasis : JTH.
[9] F. Gannon,et al. Evaluation of a PCR assay for detection of Mycobacterium tuberculosis in clinical specimens. , 1995, Diagnostic microbiology and infectious disease.
[10] C. Heiner,et al. New dye-labeled terminators for improved DNA sequencing patterns. , 1997, Nucleic acids research.
[11] J. Goedert,et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. , 1996, JAMA.
[12] S. Bowden,et al. Evaluation Of The Roche Amplicor™ Polymerase Chain Reaction System For Detection Of Mycobacterium Tuberculosis Complex In Specimens , 1996, Pathology.
[13] B. Shastry,et al. Pharmacogenetics and the concept of individualized medicine , 2006, The Pharmacogenomics Journal.
[14] G. Scott,et al. A nosocomial outbreak due to non-encapsulated Haemophilus influenzae: analysis of plasmids coding for antibiotic resistance. , 1994, The Journal of hospital infection.
[15] S. Kohno,et al. Detection of Bacteroides fragilis in clinical specimens by PCR , 1994, Journal of clinical microbiology.
[16] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[17] C. Jeney,et al. Detection and typing of 46 genital human papillomaviruses by the L1F/L1R primer system based multiplex PCR and hybridization. , 2007, Journal of virological methods.
[18] Alexander Mathis,et al. PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs , 1995, Journal of clinical microbiology.
[19] A. Daly,et al. Pharmacogenetics of oral anticoagulants. , 2003, Pharmacogenetics.
[20] Dan M Roden,et al. Genetic determinants of response to warfarin during initial anticoagulation. , 2008, The New England journal of medicine.
[21] R. Bernards,et al. Enabling personalized cancer medicine through analysis of gene-expression patterns , 2008, Nature.
[22] J. Glass,et al. Sequencing multimegabase-template DNA with BigDye terminator chemistry. , 1998, Genome research.
[23] P. Farci,et al. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359-362]. , 2002, Journal of hepatology.
[24] G. Dasch,et al. Identification of Rickettsia conorii infection by polymerase chain reaction in a soldier returning from Somalia. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] E S Kawasaki,et al. Single-base mutational analysis of cancer and genetic diseases using membrane bound modified oligonucleotides. , 1991, Nucleic acids research.
[26] B. Irvine,et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[27] J. Bartholomew,et al. An algorithm for managing warfarin resistance , 2009, Cleveland Clinic Journal of Medicine.
[28] H. Echizen,et al. Pharmacogenetics of Warfarin Elimination and its Clinical Implications , 2001, Clinical pharmacokinetics.
[29] G. Zissis,et al. Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma , 1996, Journal of clinical microbiology.
[30] S. Szefler. HIV-1 MESSENGER RNA IN PERIPHERAL BLOOD MONONUCLEAR CELLS AS AN EARLY MARKER OF RISK FOR PROGRESSION TO AIDS , 1996, Pediatrics.
[31] L. Engstrand,et al. Immunomagnetic separation and PCR for detection of Helicobacter pylori in water and stool specimens , 1995, Journal of clinical microbiology.
[32] J. Mansour,et al. Molecular mechanisms for individualized cancer care. , 2008, Journal of the American College of Surgeons.
[33] J. Lindon,et al. Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.
[34] J. Mellors,et al. Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion , 1995, Annals of Internal Medicine.